Suchergebnisse - "Pariente, Benjamin"

PubPharm (16)

1

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease

enthalten in: United European gastroenterology journal | 2021

von Buisson, A. | Nancey, S. | Manlay, L. | +11

2

Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Bossuyt, P. | Dreesen, E. | Rimola, J. | +31

3

Clinical guidelines for the management of inflammatory bowel disease : Update of a French national consensus

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2021

von Amiot, A. | Bouguen, G. | Bonnaud, G. | +44

4

Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease : A Post Hoc Analysis of TAILORIX

enthalten in: The American journal of gastroenterology | 2021

von Rivière, P. | D'Haens, G. | Peyrin-Biroulet, L. | +8

5

Ustekinumab for Perianal Crohn's Disease : The BioLAP Multicenter Study From the GETAID

enthalten in: The American journal of gastroenterology | 2020

von Chapuis-Biron, C. | Kirchgesner, J. | Pariente, B. | +23

6

Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2020

von Martin, A. | Nachury, M. | Peyrin-Biroulet, L. | +62

7

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Dreesen, E. | Baert, F. | Laharie, D. | +12

CommentIn: Clin Gastroenterol Hepatol. 2020 Jan;18(1):262. - PMID 31220636

8

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Dulai, P. | Amiot, A. | Peyrin-Biroulet, L. | +95

CommentIn: Aliment Pharmacol Ther. 2020 Apr;51(7):738-739. - PMID 32162371

9

Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease

enthalten in: Joint bone spine | 2019

von Paccou, J. | Nachury, M. | Duchemin, C. | +3

10

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease : A GETAID Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2019

von Caron, B. | Peyrin-Biroulet, L. | Pariente, B. | +21

CommentIn: J Crohns Colitis. 2019 Sep 27;13(10):1237-1238. - PMID 31560065